Professional Documents
Culture Documents
(Year) : Type The Document Title
(Year) : Type The Document Title
A research report is submitted in partial fulfillment requirement for assignment of research methodology of medicine and surgery of Amoud University
Borama Somaliland
May 2012
Acknowledgements
Firstly,It is almightily praise to Allah, the creator of the world. Second I would like to thank all of my friends who encouraged me to make this research and all of them who helped and made me possible to carry out this task.
Research contents 1: Introduction to peptic ulcer disease 2: peptic ulcer disease in borama 3: the causes of peptic ulcer disease 4: effects to population in borama
PUD occurs most commonly in duodenal bulb (duodenal ulcerDU) and stomach (gastric ulcerGU). It may also occur in esophagus, pyloric channel, duodenal loop, jejunum, Meckels diverticulum. PUD results when aggressive factors (gastric acid, pepsin) overwhelm defensive factors involved in mucosal resistance (gastric mucus, bicarbonate, microcirculation, prostaglandins, mucosal barrier), and from effects of Helicobacter pylori. Peptic ulcer disease is one of the common diseases in this community, and it became the most widespread disease that is diagnosed by many people every day. Although it is not recorded well the cases that encountered in the hospital, I tried to make some research that helps me feel the problem which faces our community when I was doing my normal duty and my education in the hospital. In fact it is difficult to get the correct information about this problem,
because there is no record that I can get the former information such cases before years or decades so the classification of the increasing and decreasing of the disease is very difficult. But in my trail research, it seems that this disease increases fast as compared to other chronic diseases. This disease has major effect in this community ( especially the people who live low life but not always true).Although this is the normal disease of this community geographically, it may exist the other community outside this community. There are many things that induced me to know this problem such the increasing the number of people who died the outcomes or the consequences from it, the increasing number of the people who are suffering from it and complaining its troublesome effects. Epidemiologically this disease varies throughout the world and depends largely on the overall standard of living in the region. In developing parts of the world, 80% of the population may be infected by the age of 20, whereas the prevalence is 2050% in industrialized countries. In contrast, in the United States this organism is rare in childhood.
In my view point, I believe that there are many things which causes this disease in this town, either can be life style such as food, water and importing materials such as oil or psychological problems like stress which is the major contributor of this disease. So I am informing the researchers to do this condition which is getting worse day after day.
TREATMENT
Objectives: pain relief, healing, prevention of complications, prevention of recurrences. For GU, exclude malignancy (follow endoscopically to healing). Dietary restriction unnecessary with contemporary drugs; discontinue NSAIDs; smoking may prevent healing and should be stopped. Eradication of H. pylori markedly reduces rate of ulcer relapse and is indicated for all DUs and GUs associated with H. pylori (Table 150-2). Acid suppression is generally included in regimen. Standard drugs (H2-receptor blockers, sucralfate, antacids) heal 8090% of DUs and 60% of GUs in 6 weeks; healing is more rapid with omeprazole (20 mg/d). Surgery For complications (persistent or recurrent bleeding, obstruction, perforation) or, uncommonly, intractability (first screen for surreptitious NSAID use and gastrinoma).
TRIPLE THERAPY
1. Bismuth subsalicylate plus Metronidazole plus Tetracyclinea 2. Ranitidine bismuth citrate plus Tetracycline plus Clarithromycin or metronidazole 3. Omeprazole (lansoprazole) plus Clarithromycin plus Metronidazoleb or Amoxicillinc 1 g bid 2 tablets qid 250 mg qid 500 mg qid 400 mg bid 500 mg bid 500 mg bid 20 mg bid (30 mg bid) 250 or 500 mg bid 500 mg bid
dose
QUADRUPLE THERAPY
Omeprazole (lansoprazole) Bismuth subsalicylate Metronidazole Tetracycline 20 mg (30 mg) daily 2 tablets qid 250 mg qid 500 mg qid